Sage Journals: Discover world-class research

Abstract

Keywords

Drug Therapy Factors That Modify Patient Response to Drug Therapy Factors that Modify Patient Records Pharmacists Role

Get full access to this article

View all access options for this article.

References

Hartshorn

E. A.

: Physiological States Altering Response to Drugs, Drug Intelligence 3: 14–20 (Jan.) 1969.

Wagner

J.G.

: Biopharmaceutics, 17. Role of Dissolution In Vitro and In Vivo, Part II. Introduction and Historical Highlights, Drug Intell. Clin. Pharm. 4: 32–37 (Feb.) 1970.

Smith

R. N.

: Generic Equivalence and Non-Equivalence of Drugs, Lancet 2: 528–530 (Sept. 9) 1972.

Wagner

J.G.

: Generic Equivalence and Inequivalence of Oral Products, Drug Intell. Clin. Pharm. 5: 115–128 (Apr.) 1971.

Prescott

L.F.

: Generic Inequivalence—Clinical Observation, Acta Pharmacol. Toxicol. 29: 288–303 (Suppl. 3) 1971.

Levy

: The Pharmacist's Role in Product Selection, Drug Intell. Clin. Pharm. 6: 18–20 (Jan.) 1972.

Wagner

J.G.

: Biopharmaceutics, 5. Mechanisms of Gastrointestinal Absorption of Drugs, Drug Intelligence 2: 181–186 (July) 1968.

Anderson

: Variations in Gastrointestinal Functions Influencing the Absorption of Drugs, Acta Pharmacol. Toxicol. 29: 103–108 (Suppl. 3) 1971.

Wagner

J.G.

: Biopharmaceutics, Influence of Formulation on Therapeutic Activity, 1. Definitions, Scope and Relationship to Gastrointestinal Physiology, Drug Intelligence 2: 30–34 (Feb.) 1968.

10.

Conney

A.H.

: Drug Metabolism & Therapeutics, N. E. J. Med. 280: 653–659 (Mar. 20) 1969.

11.

Yaffe

S.J.

: Developmental Aspects of Pharmacokinetics, Acta Pharmacol. Toxicol. 25: 240–248 (Suppl. 3) 1971.

12.

Ritschel

W.A.

: Biological Half-Lives of Drugs, Drug Intell. Clin. Pharm. 4: 323–345 (Dec.) 1970.

13.

McCane

R.A.

: Renal Physiology in Infancy, Amer. J. Med. 9: 229 (Aug.) 1958.

14.

Odell

G.B.

: The Dissolution of Bilirubin From Albumin and Its Clinical Implications, J. Pediat. 55: 268 (Sept.) 1959.

15.

Wagner

J.G.

: Biopharmaceutics, 2. Excretion and Metabolism of Drugs, Nomeclature and Symbolism, Fundamental Principles and Concepts, Drug Intelligence 2: 80–85 (Apr.) 1968.

16.

Shirkey

H.C.

: Pediatric Dosage Handbook, American Pharmaceutical Association, Washington, D.C., 1971.

17.

Yaffe

J.T.

: Antibiotic Dosages in Newborn and Premature Infants, J. Amer. Med. Assoc. 193: 818–820 (Sept. 6) 1965.

18.

Medovy

: Therapeutic Hazards of the Nursery Infant, Postgrad Med. 34: 537–545, 1963.

19.

Meyler

, and Herxheimer

(Eds): Side Effects of Drugs, Williams & Wilkins, Co., Baltimore, 1968.

20.

Martin

E.W.

: Hazards of Medication, J.B. Lippincott Co., Philadelphia, Pa. 1971.

21.

Friedman

S.A.

: Functional Defects in the Aging Kidney, Ann. Intern. Med. 76: 41–45 (Jan.) 1972.

22.

Bertler

: Plasma Levels of Digoxin in Relation to Toxicity, Acta Pharmacol. Toxicol. 29: 281–287 (Suppl. 3) 1971.

23.

Belleville

: Influence of Age on Pain Relief from Analgesics, J. Amer. Med. Assoc. 217: 1835–1841 (Sept. 27) 1971.

24.

O'Malley

: Effects of Age and Sex on Human Drug Metabolism, Brit. Med. J. 2: 667–669 (Sept. 11) 1971.

25.

Groves : Digoxin Metabolism in Obesity, Circulation 44: Suppl. 2. Abstract. 124, (Oct.) 1971.

26.

Bantig

, and Cohen

: Excretion of Drugs in Human Milk, Hosp. Formul. Manag. 4: 14 (Apr.) 1969.

27.

Knowles

: Excretion of Drugs in Milk, J. Pediat. 66: 1068–1082 (No. 6) 1965.

28.

Shore

M.F.

: Drugs Can be Dangerous During Pregnancy and Lactation, Can. Pharm. J. (Dec.) 1970.

29.

Evans

D.A.

: Inter-Individual Differences in Metabolism of Drugs: The Role of Genetic Factors, Acta Pharmacol. Toxicol. 29: 156–162 (Suppl. 3) 1971.

30.

Committee on Problems of Drug Safety, Drug Research Board, National Academy of Sciences-National Research Council: Application of Metabolic Data to the Evaluation of Drugs, Clin. Pharmacol. Ther. 10: 607–634 (No. 5) 1970.

31.

LaDu

B.N.

: Fundamentals of Drug Metabolism and Drug Disposition, Chapter 15, Williams & Wilkins, Baltimore, 1971, pp. 308–327.

32.

Abbatiello

: Pharmacogenetics: A New Concept in Drug Response, Hosp. Pharm. 7: 263–266 (Aug.) 1972.

33.

Ellard

C.A.

: Pharmacology of Some Slow-Release Preparations of Isoniazid of Potential Use in Intermittent Treatment of T.B., Lancet: 340–343 (Feb. 12) 1972.

34.

Zacest

: Relation of Hydralazine Plasma Concentration to Dosage and Hypotensive Action, Clin. Pharmacol. Ther. 13: 420–425 (May-June) 1972.

35.

Goodman

L.S.

, and Gilman

: The Pharmacological Basis of Therapeutics, 4th Edition, The McMillan Co., New York, 1970, pp. 22–28.

36.

Gergersen

B.S.

: Pharmacology in Nursing, C.V. Mosby Co., St. Louis, Mo., 1969, pp. 91–4.

37.

Hunninghake

: Variable Drug Responses in Man, Postgrad Med. 51: 156–161 (Apr.) 1972.

38.

Faigle

J.W.

: Blood Levels of a Schisosomicide in Relation to Liver Function and Side Effects, Acta Pharmacol. Toxicol. 29: 233–239 (Suppl. 3) 1971.

39.

Anton

A.H.

: Inter-Individual Differences in the Protein Binding of Sulfonamides: The Effect of Disease and Drugs, Acta Pharmacol. Toxicol. 29: 134–150 (Suppl. 3) 1971.

40.

Breckenridge

: Pathophysiological Factors Influencing Drug Kinetics, Acta Pharmacol. Toxicol. 29: 225–232 (Suppl. 3) 1971.

41.

Kolmodin

: Effect of Environmental Factors on Drug Metabolism: Decreased Plasma Half-Life of Antipyrine in Workers Exposed to Chlorinated Hydrocarbon Insecticides, Clin. Pharmacol. Ther. 10: 638–642 (Sept.-Oct.) 1969.

Factors that Modify Drug Activity and Patient Response

Abstract

Keywords

Get full access to this article

References